Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Rheumatology Advances in Practice|May 29, 2024
Comparing clinical profiles in spondyloarthritis with Crohn's disease or ulcerative colitis: insights from the ASAS-PerSpA studyValeria Rios Rodriguez, Tugba Izci Duran, Murat Torgutalp, et al.Rheumatology (Oxford, England)|June 16, 2011
Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcomeXenofon Baraliakos, Joachim Listing, Claudia Fritz, et al.Rheumatology (Oxford, England)|May 25, 2020
Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritisDenis Poddubnyy, Henning Weineck, Torsten Diekhoff, et al.The Journal of Rheumatology|July 17, 2014
Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trialIn-Ho Song, Kay-Geert Hermann, Hildrun Haibel, et al.Journal of Autoimmunity|September 17, 2022
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritisKatharina Deschler, Judith Rademacher, Sonja M Lacher, et al.Therapeutic Advances in Musculoskeletal Disease|March 13, 2025
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANEValeria Rios Rodriguez, Lidia Sánchez-Riera, Hildrun Haibel, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2026
High-resolution deep learning DIXON MRI of the sacroiliac joints is non-inferior to standard MRI in patients with suspected axial SpondyloarthritisDominik Deppe, Mariam Koka, Fabian Proft, et al.Annals of the Rheumatic Diseases|March 24, 2012
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trialIn-Ho Song, Christian E Althoff, Hildrun Haibel, et al.The Journal of Rheumatology|February 15, 2007
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitisXenofon Baraliakos, Joachim Listing, Martin Rudwaleit, et al.Rheumatology (Oxford, England)|October 26, 2023
Self-reported diagnostic confidence predicts diagnostic accuracy in axial spondyloarthritis imagingSevtap Tugce Ulas, Felix Radny, Katharina Ziegeler, et al.Pageof 9